• Garmin Ltd. (NASDAQ:GRMN) reported Q4 EPS of $0.83, lower than the Zacks Consensus Estimate of $0.87 per share. Revenues for the quarter fell 21% year-over-year to $838.0 million, missing the Zacks Consensus Estimate of $860.0 million
• Chico’s FAS, Inc. (NYSE:CHS) reported Q4 EPS of $0.12, slightly lower than the Zacks Consensus Estimate of $0.13 per share. Revenues for the quarter rose 9% year-over-year to $475.0 million, above the Zacks Consensus Estimate of $473.0 million
• Limited Brands (NYSE:LTD) reported Q4 EPS of $1.26, ex-items, beating the Zacks Consensus Estimate of $1.25 per share. Revenues for the quarter rose to $3.46 billion, above the Zacks Consensus Estimate of $3.397 billion
• Avago Technologies (NASDAQ:AVGO) reported Q1 EPS of $0.65, above the Zacks Consensus Estimate of $0.53 per share. Revenues for the quarter rose 21% year-over-year to $550.0 million, beating the Zacks Consensus Estimate of $547.0 million
• The TJX Companies, Inc. (NYSE:TJX) reported a disappointing sales outlook and the company’s shares dropped 2%
• Enterprise Products Partners LP (NYSE:EPD) said it has offered to buy Duncan Energy Partners LP (NYSE:DEP) for around $2.41 billion
• A late-stage study showed that an experimental drug from Vertex Pharmaceuticals Inc (NASDAQ:VRTX) improved lung function in cystic fibrosis patients. Reacting to the news the company’s share prices gained 15%
AVAGO TECHNOLOG (AVGO): Free Stock Analysis Report
CHICOS FAS INC (CHS): Free Stock Analysis Report
DUNCAN ENERGY (DEP): Free Stock Analysis Report
ENTERPRISE PROD (EPD): Free Stock Analysis Report
GARMIN LTD (GRMN): Free Stock Analysis Report
LIMITED INC (LTD): Free Stock Analysis Report
TJX COS INC NEW (TJX): Free Stock Analysis Report
VERTEX PHARM (VRTX): Free Stock Analysis Report
Zacks Investment Research
